212 related articles for article (PubMed ID: 34365492)
1. (-)-Epicatechin gallate blocks the development of atherosclerosis by regulating oxidative stress
Yu J; Li W; Xiao X; Huang Q; Yu J; Yang Y; Han T; Zhang D; Niu X
Food Funct; 2021 Sep; 12(18):8715-8727. PubMed ID: 34365492
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effect of (-)-Epicatechin gallate on the proliferation and migration of vascular smooth muscle cells weakens and stabilizes atherosclerosis.
Li W; Yu J; Xiao X; Li W; Zang L; Han T; Zhang D; Niu X
Eur J Pharmacol; 2021 Jan; 891():173761. PubMed ID: 33249078
[TBL] [Abstract][Full Text] [Related]
3. (-)-Epicatechin gallate blocked cellular foam formation in atherosclerosis by modulating CD36 expression
Yu J; Zhou L; Song H; Huang Q; Yu J; Wang S; Zhang X; Li W; Niu X
Food Funct; 2023 Mar; 14(5):2444-2458. PubMed ID: 36786689
[TBL] [Abstract][Full Text] [Related]
4. Poria cocos polysaccharides attenuated ox-LDL-induced inflammation and oxidative stress via ERK activated Nrf2/HO-1 signaling pathway and inhibited foam cell formation in VSMCs.
Zhao J; Niu X; Yu J; Xiao X; Li W; Zang L; Hu Z; Siu-Po Ip P; Li W
Int Immunopharmacol; 2020 Mar; 80():106173. PubMed ID: 31945610
[TBL] [Abstract][Full Text] [Related]
5. Txnip ablation reduces vascular smooth muscle cell inflammation and ameliorates atherosclerosis in apolipoprotein E knockout mice.
Byon CH; Han T; Wu J; Hui ST
Atherosclerosis; 2015 Aug; 241(2):313-21. PubMed ID: 26062991
[TBL] [Abstract][Full Text] [Related]
6. SOAT1 deficiency attenuates atherosclerosis by regulating inflammation and cholesterol transportation via HO-1 pathway.
Wu N; Li RQ; Li L
Biochem Biophys Res Commun; 2018 Jun; 501(2):343-350. PubMed ID: 29567472
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin gallate attenuates proliferation and oxidative stress in human vascular smooth muscle cells induced by interleukin-1β via heme oxygenase-1.
Liu PL; Liu JT; Kuo HF; Chong IW; Hsieh CC
Mediators Inflamm; 2014; 2014():523684. PubMed ID: 25386047
[TBL] [Abstract][Full Text] [Related]
8. TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1.
Zhang L; Cheng H; Yue Y; Li S; Zhang D; He R
Cardiovasc Pathol; 2018; 33():6-15. PubMed ID: 29268138
[TBL] [Abstract][Full Text] [Related]
9. Increased atherosclerosis and vascular smooth muscle cell activation in AIF-1 transgenic mice fed a high-fat diet.
Sommerville LJ; Kelemen SE; Ellison SP; England RN; Autieri MV
Atherosclerosis; 2012 Jan; 220(1):45-52. PubMed ID: 21862018
[TBL] [Abstract][Full Text] [Related]
10. Sinigrin attenuates the progression of atherosclerosis in ApoE
Jang YJ; Park B; Lee HW; Park HJ; Koo HJ; Kim BO; Sohn EH; Um SH; Pyo S
Chem Biol Interact; 2017 Jun; 272():28-36. PubMed ID: 28483571
[TBL] [Abstract][Full Text] [Related]
11. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
[TBL] [Abstract][Full Text] [Related]
12. Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction.
Loke WM; Proudfoot JM; Hodgson JM; McKinley AJ; Hime N; Magat M; Stocker R; Croft KD
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):749-57. PubMed ID: 20093625
[TBL] [Abstract][Full Text] [Related]
13. Artesunate inhibits atherosclerosis by upregulating vascular smooth muscle cells-derived LPL expression via the KLF2/NRF2/TCF7L2 pathway.
He LH; Gao JH; Yu XH; Wen FJ; Luo JJ; Qin YS; Chen MX; Zhang DW; Wang ZB; Tang CK
Eur J Pharmacol; 2020 Oct; 884():173408. PubMed ID: 32739175
[TBL] [Abstract][Full Text] [Related]
14. Effect of miR-663 on atherosclerosis by regulating the proliferation of vascular smooth muscle cells in lipid plaques.
Deng Z; Li L
Vascular; 2023 Dec; 31(6):1240-1252. PubMed ID: 35599617
[TBL] [Abstract][Full Text] [Related]
15. SCAP knockdown in vascular smooth muscle cells alleviates atherosclerosis plaque formation via up-regulating autophagy in ApoE
Li D; Chen A; Lan T; Zou Y; Zhao L; Yang P; Qu H; Wei L; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
FASEB J; 2019 Mar; 33(3):3437-3450. PubMed ID: 30462530
[TBL] [Abstract][Full Text] [Related]
16. Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation.
Harada N; Ito K; Hosoya T; Mimura J; Maruyama A; Noguchi N; Yagami K; Morito N; Takahashi S; Maher JM; Yamamoto M; Itoh K
Free Radic Biol Med; 2012 Dec; 53(12):2256-62. PubMed ID: 23051009
[TBL] [Abstract][Full Text] [Related]
17. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
Sato K; Shirai R; Hontani M; Shinooka R; Hasegawa A; Kichise T; Yamashita T; Yoshizawa H; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411243
[TBL] [Abstract][Full Text] [Related]
18. Disocin prevents postmenopausal atherosclerosis in ovariectomized LDLR-/- mice through a PGC-1α/ERα pathway leading to promotion of autophagy and inhibition of oxidative stress, inflammation and apoptosis.
Yang Q; Wang C; Jin Y; Ma X; Xie T; Wang J; Liu K; Sun H
Pharmacol Res; 2019 Oct; 148():104414. PubMed ID: 31449974
[TBL] [Abstract][Full Text] [Related]
19. The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(-/-) mice.
Liu Z; Han Y; Li L; Lu H; Meng G; Li X; Shirhan M; Peh MT; Xie L; Zhou S; Wang X; Chen Q; Dai W; Tan CH; Pan S; Moore PK; Ji Y
Br J Pharmacol; 2013 Aug; 169(8):1795-809. PubMed ID: 23713790
[TBL] [Abstract][Full Text] [Related]
20. Lunasin attenuates oxidant-induced endothelial injury and inhibits atherosclerotic plaque progression in ApoE
Gu L; Ye P; Li H; Wang Y; Xu Y; Tian Q; Lei G; Zhao C; Gao Z; Zhao W; Tan S
FASEB J; 2019 Apr; 33(4):4836-4850. PubMed ID: 30601695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
